Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NBI-74788 in Adults With Congenital Adrenal Hyperplasia
Condition:   Congenital Adrenal Hyperplasia Intervention:   Drug: NBI-74788 Sponsor:   Neurocrine Biosciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 16, 2018 Category: Research Source Type: clinical trials